Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo

被引:44
作者
Beier, Kevin T. [1 ,2 ,3 ]
Saunders, Arpiar B. [3 ,4 ]
Oldenburg, Ian A. [3 ,4 ]
Sabatini, Bernardo L. [3 ,4 ]
Cepko, Constance L. [1 ,2 ,3 ]
机构
[1] Harvard Univ, Harvard Med Sch, Dept Genet, Boston, MA 02115 USA
[2] Harvard Univ, Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA
[3] Howard Hughes Med Inst, Boston, MA 02115 USA
[4] Harvard Univ, Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA
来源
FRONTIERS IN NEURAL CIRCUITS | 2013年 / 7卷
关键词
vesicular stomatitis virus; transsynaptic infection; rabies; retrograde transneuronal tracing; in vivo; technology; polysynaptic; CENTRAL-NERVOUS-SYSTEM; SUBCAPSULAR SINUS MACROPHAGES; CELLULAR IMMUNE-RESPONSES; LONG-TERM PROTECTION; MATRIX PROTEIN; TRANSNEURONAL TRACER; ADENOASSOCIATED VIRUS; GENE-EXPRESSION; CVS STRAIN; INFECTION;
D O I
10.3389/fncir.2013.00011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Defining the connections among neurons is critical to our understanding of the structure and function of the nervous system. Recombinant viruses engineered to transmit across synapses provide a powerful approach for the dissection of neuronal circuitry in vivo. We recently demonstrated that recombinant vesicular stomatitis virus (VSV) can be endowed with anterograde or retrograde transsynaptic tracing ability by providing the virus with different glycoproteins. Here we extend the characterization of the transmission and gene expression of recombinant VSV (rVSV) with the rabies virus glycoprotein (RABV-G), and provide examples of its activity relative to the anterograde transsynaptic tracer form of rVSV. rVSV with RABV-G was found to drive strong expression of transgenes and to spread rapidly from neuron to neuron in only a retrograde manner. Depending upon how the RABV-G was delivered, VSV served as a polysynaptic or monosynaptic tracer, or was able to define projections through axonal uptake and retrograde transport. In animals co-infected with rVSV in its anterograde form, rVSV with RABV-G could be used to begin to characterize the similarities and differences in connections to different areas. rVSV with RABV-G provides a flexible, rapid, and versatile tracing tool that complements the previously described VSV-based anterograde transsynaptic tracer.
引用
收藏
页数:13
相关论文
共 66 条
[41]   Dural headache and innervation of the dura mater [J].
Penfield, W ;
McNaughton, F .
ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1940, 44 (01) :43-75
[42]   The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes [J].
Petersen, JM ;
Her, LS ;
Varvel, V ;
Lund, E ;
Dahlberg, JE .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (22) :8590-8601
[43]   Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses [J].
Publicover, J ;
Ramsburg, E ;
Rose, JK .
JOURNAL OF VIROLOGY, 2004, 78 (17) :9317-9324
[44]   Rhabdovirus Evasion of the Interferon System [J].
Rieder, Martina ;
Conzelmann, Karl-Klaus .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2009, 29 (09) :499-509
[45]   Emergence and re-emergence of vesicular stomatitis in the United States [J].
Rodríguez, LL .
VIRUS RESEARCH, 2002, 85 (02) :211-219
[46]   Vesicular stomatitis virus vectors expressing avian influenza H5HA induce cross-neutralizing antibodies and long-term protection [J].
Schwartz, Jennifer A. ;
Buonocore, Linda ;
Roberts, Anjeanette ;
Suguitan, Amorsolo, Jr. ;
Kobasa, Darwyn ;
Kobinger, Gary ;
Feldmann, Heinz ;
Subbarao, Kanta ;
Rose, John K. .
VIROLOGY, 2007, 366 (01) :166-173
[47]   MOUSE MODEL FOR ABORTIVE RABIES INFECTION OF THE CENTRAL NERVOUS-SYSTEM [J].
SMITH, JS .
INFECTION AND IMMUNITY, 1981, 31 (01) :297-308
[48]   INNERVATION OF THE HEART AND ITS CENTRAL MEDULLARY ORIGIN DEFINED BY VIRAL TRACING [J].
STANDISH, A ;
ENQUIST, LW ;
SCHWABER, JS .
SCIENCE, 1994, 263 (5144) :232-234
[49]   VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents [J].
Stojdl, DF ;
Lichty, BD ;
tenOever, BR ;
Paterson, JM ;
Power, AT ;
Knowles, S ;
Marius, R ;
Reynard, J ;
Poliquin, L ;
Atkins, H ;
Brown, EG ;
Durbin, RK ;
Durbin, JE ;
Hiscott, J ;
Bell, JC .
CANCER CELL, 2003, 4 (04) :263-275
[50]   Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus [J].
Stojdl, DF ;
Lichty, B ;
Knowles, S ;
Marius, R ;
Atkins, H ;
Sonenberg, N ;
Bell, JC .
NATURE MEDICINE, 2000, 6 (07) :821-825